Finance

Lists
COR:NYSE
Cencora Inc
347,53 USD
-0,86%
(-3,03) 1D
18-ноя., 14:28:46 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COR...
Open
347,16 USD
High
349,84 USD
Low
344,49 USD
Mkt. cap
15,34 млд
Avg. vol.
1,33 млн
Volume
440,88 миң
52-wk high
377,54 USD
52-wk low
244,82 USD
Beta
0,58
Shares outstanding
190,83 млн
No. of employees
49 миң
Open
347,16 USD
High
349,84 USD
Low
344,49 USD
Mkt. cap
15,34 млд
Avg. vol.
1,33 млн
Volume
440,88 миң
52-wk high
377,54 USD
52-wk low
244,82 USD
Beta
0,58
Shares outstanding
190,83 млн
No. of employees
49 миң
News stories
From web sources and news partners
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49 миң
Founded1871
Headquarters-
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 11 analysts giving stock ratings to COR in the past 3 months
Strong buy
Buy
9
Hold
2
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for COR in the last 3 months.
Highest
Current 347,53 USD
415,00 USD (+19,41%)
Average
387,73 USD (+11,57%)
Lowest
330,00 USD (-5,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Reiterated
415,00 USD
+19,4%
11/17/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
400,00 USD
+15,1%
11/17/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
360,00 USD
+3,6%
11/10/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
413,00 USD
+18,8%
11/10/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
405,00 USD
+16,5%
11/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
380,00 USD
+9,3%
11/05/2026
Ryan Halsted
RBC Capital
Hold
Reiterated
330,00 USD
-5%
11/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
405,00 USD
+16,5%
11/05/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
377,00 USD
+8,5%
10/30/2026
David Toung
Argus Research
Buy
Maintained
380,00 USD
+9,3%
10/20/2026
Kevin Caliendo
UBS
Buy
Maintained
400,00 USD
+15,1%
10/16/2026
Charles Rhyee
TD Cowen
Buy
Maintained
400,00 USD
+15,1%
08/09/2026
Daniel Grosslight
Citi
Buy
Maintained
370,00 USD
+6,5%
08/06/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
08/05/2026
Max Smock
William Blair
Hold
Maintained
-
-
05/22/2026
Last report
2026-ж., 4-ноя.
Fiscal period
Q4 2026
4,66 USD / 4,57 USD
+1,88%beat
Revenue / Est. (USD)
88,35 млд / 87,91 млд
+0,50%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
85,93 млд
78,36 млд
84,75 млд
88,35 млд
Cost of goods sold
82,87 млд
74,78 млд
81,15 млд
84,79 млд
Cost of revenue
82,87 млд
74,78 млд
81,15 млд
84,79 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,80 млд
1,98 млд
2,13 млд
2,17 млд
Operating expense
2,06 млд
2,23 млд
2,40 млд
2,44 млд
Total operating expenses
84,93 млд
77,01 млд
83,56 млд
87,23 млд
Operating income
1,00 млд
1,34 млд
1,20 млд
1,12 млд
Other non operating income
10,10 млн
-173,00 миң
16,88 млн
16,69 млн
EBT including unusual items
708,64 млн
2,09 млд
996,39 млн
787,21 млн
EBT excluding unusual items
941,56 млн
1,20 млд
1,08 млд
1,00 млд
Income tax expense
142,51 млн
459,04 млн
219,73 млн
258,11 млн
Effective tax rate
20,11%
21,98%
22,05%
32,79%
Other operating expenses
362,00 миң
595,00 миң
881,00 миң
-
Net income
559,65 млн
1,64 млд
763,52 млн
519,40 млн
Net profit margin
0,65%
2,09%
0,90%
0,59%
Earnings per share
4,08
4,75
4,48
4,66
Interest and investment income
20,95 млн
13,88 млн
13,82 млн
-
Interest expense
-93,36 млн
-154,34 млн
-154,52 млн
-136,29 млн
Net interest expenses
-72,41 млн
-140,46 млн
-140,70 млн
-136,29 млн
Depreciation and amortization charges
134,29 млн
132,14 млн
150,96 млн
266,24 млн
EBITDA
1,27 млд
1,60 млд
1,47 млд
1,37 млд
Gain or loss from assets sale
-35,82 млн
-234,00 миң
-15,96 млн
52,02 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору